ZDHHC9 and pancreatic neoplasm: In pancreatic cancer, knockdown of ZDHHC3 impaired tumor progression in a xenograft mice model [58], whereas inactivation of ZDHHC9 modified the tumor microenvironment from an immunosuppressive to a proinflammatory environment and, thus, suppressed tumor growth [59].